Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
BiondVax Pharmaceuticals NASDAQ BVXV
$0.69 0.0100 1.45%
Today share price
Israel
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 24 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

2.33M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
8.72M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.31
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
3.38M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-
Upcoming events BiondVax Pharmaceuticals All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart BiondVax Pharmaceuticals

Stock analysis BiondVax Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
0.14 -88.65
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-1.32 12.43
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.64 -27.80
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-0.47 0.61
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-242.19 -1.16

Price change BiondVax Pharmaceuticals per year

2.03$ 43.57$
Min Max

Summary analysis BiondVax Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure BiondVax Pharmaceuticals

Revenue and net income BiondVax Pharmaceuticals

All parameters
Stock news BiondVax Pharmaceuticals All news
16 December 2022 в 17:25

BiondVax Pharmaceuticals $8 Million Public Offering Prices

16 December 2022 в 17:25

BiondVax Pharmaceuticals $8 Million Public Offering Prices

22 December 2021 в 16:15

BiondVax Pharmaceuticals ADRs 56% Higher After Deal for Nanosized Covid-19 Antibody Therapies

22 December 2021 в 16:10

BiondVax Pharmaceuticals ADRs 56% Higher After Deal for Nanosized Covid-19 Antibody Therapies

About company BiondVax Pharmaceuticals

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and related illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Address:
Jerusalem BioPark Building, Jerusalem, Israel, 7414002
Company name: BiondVax Pharmaceuticals
Issuer ticker: BVXV
ISIN: US09073Q1058
Country: Israel
Exchange: NASDAQ
Currency: $
IPO date: 2015-05-12
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.biondvax.com

On which stock exchange are BiondVax Pharmaceuticals (BVXV) stocks traded?

BiondVax Pharmaceuticals (BVXV) stocks are traded on NASDAQ.

What is the ticker of BiondVax Pharmaceuticals stocks (BVXV)?

The stock ticker of BiondVax Pharmaceuticals’s stocks or in other words, the code is BVXV. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does BiondVax Pharmaceuticals (BVXV) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, BiondVax Pharmaceuticals (BVXV) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are BiondVax Pharmaceuticals (BVXV) stocks traded?

BiondVax Pharmaceuticals (BVXV) stocks are traded on the NASDAQ exchange in dollars.

What is the price of BiondVax Pharmaceuticals (BVXV) stocks today?

The current price of BiondVax Pharmaceuticals stocks on 18.04.2024 is 0.69 dollars. per share.

What is the dynamics of BiondVax Pharmaceuticals (BVXV) stocks from the beginning of the year?

BiondVax Pharmaceuticals (BVXV) quotes have increased by 0% from the beginning of the year up to 0.69 dollars. per 1 stocks.

How much did BiondVax Pharmaceuticals (BVXV) stocks increase in апреле 2024?

This month BiondVax Pharmaceuticals (BVXV) quotes have increased by 0% to 0.69 dollars. per share.

How much are BiondVax Pharmaceuticals (BVXV) stocks worth?

Today, on October, 18.04.2024 BiondVax Pharmaceuticals’s (BVXV) stocks cost 0.69 dollars..

What is the market capitalization of BiondVax Pharmaceuticals (BVXV)?

Capitalization is the market value of BiondVax Pharmaceuticals (BVXV) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 18.04.2024, the market capitalization of BiondVax Pharmaceuticals (BVXV) is estimated at about 2331941 dollars.